SCHEMBL12759590

SCHEMBL12759590

CCc1cn2c3ccccc3c3ccccc3c2n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.39
KDM4E B2RXH2 4/20 0.39
ALDH1A1 P00352 3/20 0.39
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 4/20 0.37
LMNA P02545 4/20 0.37
HSD17B10 Q99714 3/20 0.37
POLB P06746 3/20 0.37
USP2 O75604 2/20 0.37
CASP1 P29466 2/20 0.37
CASP7 P55210 2/20 0.37
TP53 P04637 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
PGR P06401 1/20 0.37
RORA P35398 1/20 0.37
RORC P51449 1/20 0.37
RORB Q92753 1/20 0.37
NPC1 O15118 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29929754 0.81 ADORA2A (0.35) MAPTKDM4EALDH1A1KMT2AMEN1
SCHEMBL861330 0.77 HSD17B10 (0.47) MAPTKDM4EALDH1A1HPGDTSHR
SCHEMBL16328883 0.74 KDM4E (0.35) MAPTKDM4EALDH1A1TSHRLMNA
SCHEMBL12759589 0.73 DDB1 (0.41) MAPTKDM4EALDH1A1KMT2AMEN1
SCHEMBL12759587 0.73 MAPT (0.37) MAPTKDM4EALDH1A1KMT2AMEN1
SCHEMBL13325840 0.71 ADORA2A (0.53) KDM4EALDH1A1KMT2AMEN1HPGD
SCHEMBL12759643 0.71 GPR3 (0.33) MAPTKDM4EALDH1A1HPGDTSHR
SCHEMBL861337 0.70 PGR (0.40) MAPTKDM4EALDH1A1KMT2AMEN1
SCHEMBL3356083 0.69 ADORA2A (0.46) KDM4EALDH1A1KMT2AMEN1HPGD
SCHEMBL25857612 0.68 TOP2A (0.52) MAPTKDM4EALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150311455-A1 Method Of Forming Metal Complex Compound, And Organic Electroluminescence Device UDC IRELAND LTD (IE) 2015-10-29 US disclosed
US-20150311455-A1 Method Of Forming Metal Complex Compound, And Organic Electroluminescence Device UDC IRELAND LTD (IE) 2015-10-29 US disclosed
US-9062084-B2 Method of forming metal complex compound, and organic electroluminescence device UDC Ireland (IE) 2015-06-23 US disclosed
US-9062084-B2 Method of forming metal complex compound, and organic electroluminescence device UDC Ireland (IE) 2015-06-23 US disclosed
US-20110050093-A1 METHOD OF FORMING METAL COMPLEX COMPOUND, AND ORGANIC ELECTROLUMINESCENCE DEVICE FUJIFILM CORPORATION (JP) 2011-03-03 US disclosed
US-20110050093-A1 METHOD OF FORMING METAL COMPLEX COMPOUND, AND ORGANIC ELECTROLUMINESCENCE DEVICE FUJIFILM CORPORATION (JP) 2011-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110050093-A1 METHOD OF FORMING METAL COMPLEX COMPOUND, AND ORGANIC ELECTROLUMINESCENCE DEVICE ZFR, PORCN, OR10J3 MAPT 1946/4885KDM4E 2514/4885ALDH1A1 2296/4885
US-20150311455-A1 Method Of Forming Metal Complex Compound, And Organic Electroluminescence Device ZFR, PORCN, OR10J3 MAPT 1946/4885KDM4E 2514/4885ALDH1A1 2296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.